Standout Papers
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2010)
- Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas (2016)
- Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review (2014)
Immediate Impact
4 by Nobel laureates 8 from Science/Nature 103 standout
Citing Papers
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
2024 Standout
Cancer therapy with antibodies
2024 Standout
Works of Marc C. Chamberlain being referenced
A phase 1a dose-escalation study of PY159, a monoclonal antibody targeting TREM1 (triggering receptor expressed on myeloid cells 1).
2023
A phase 1a dose-escalation study of PY314, a TREM2 (Triggering Receptor Expressed on Macrophages 2) targeting monoclonal antibody.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marc C. Chamberlain | 10693 | 7284 | 4068 | 4076 | 326 | 17.5k | |
| Riccardo Soffietti | 11537 | 7383 | 3923 | 3409 | 247 | 18.3k | |
| Kathleen R. Lamborn | 12612 | 5496 | 3049 | 2952 | 291 | 22.3k | |
| Jan C. Buckner | 10518 | 7285 | 3632 | 1951 | 260 | 17.0k | |
| Matthias Preusser | 6667 | 5645 | 6329 | 2513 | 532 | 17.8k | |
| Caterina Giannini | 8721 | 4937 | 2408 | 5435 | 396 | 19.2k | |
| Larry E. Kun | 10015 | 5901 | 2362 | 5677 | 370 | 20.1k | |
| William M. Wara | 7633 | 5232 | 1910 | 3995 | 206 | 13.7k | |
| David Schiff | 7812 | 3742 | 2708 | 3238 | 362 | 16.4k | |
| Allan H. Friedman | 11984 | 4745 | 5537 | 5050 | 340 | 25.2k | |
| Philip H. Gutin | 6941 | 4887 | 1728 | 2489 | 240 | 14.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...